Cetera Investment Advisers
BDSX icon

Cetera Investment Advisers’s Biodesix BDSX Stock Holding History

Cetera Investment Advisers’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174K Buy
12,000
+2,000
+20% +$24.8K ﹤0.01% 4322
2025
Q4 		$68K Buy
+10,000
New +$73.7K ﹤0.01% 4470
2025
Q3 		– Sell
-500
Closed -$2.82K – 4577
2025
Q2 		$2.82K Buy
+500
New +$4.04K ﹤0.01% 4067
2024
Q4 		– Sell
-3,900
Closed -$139K – 3790
2024
Q3 		$139K Hold
3,900
– – ﹤0.01% 3473
2024
Q2 		$119K Hold
3,900
– – ﹤0.01% 3481
2024
Q1 		$112K Buy
+3,900
New +$133K ﹤0.01% 3482

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Cetera Investment Advisers's BDSX Position: Q1 2026 in Review

Cetera Investment Advisers increased its Biodesix (BDSX) stake by 20% in Q1 2026, buying an estimated $24.8K and bringing the position to 12,000 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #4322.

Cetera Investment Advisers first reported a position in BDSX in Q1 2024 and has held it in 6 quarters since. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Cetera Investment Advisers held 12,000 shares of Biodesix worth $174K as of Q1 2026.
  • Cetera Investment Advisers bought 2,000 Biodesix shares in Q1 2026, an estimated $24.8K.
  • Biodesix made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4322 holding.
  • Cetera Investment Advisers first reported a position in Biodesix in Q1 2024 and has held it in 6 quarters since.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.